Literature DB >> 17450440

Breastfeeding and risk of ovarian cancer in two prospective cohorts.

Kim N Danforth1, Shelley S Tworoger, Jonathan L Hecht, Bernard A Rosner, Graham A Colditz, Susan E Hankinson.   

Abstract

OBJECTIVE: To describe the association between breastfeeding and ovarian cancer risk in two prospective cohorts. MATERIALS &
METHODS: We pooled data from the Nurses' Health Study and Nurses' Health Study II. There were 391 cases of epithelial ovarian cancer diagnosed among 149,693 parous women with up to 16 years of follow-up. Data were analyzed using multivariate Cox proportional hazards models, controlling for age, parity, duration of oral contraceptive use, tubal ligation, and age at menarche.
RESULTS: Ever breastfeeding was associated with a non-significant reduction in ovarian cancer risk compared with never breastfeeding (RR=0.86, 95% CI 0.70-1.06); the median duration of breastfeeding among women who breastfed was nine months. Breastfeeding of 18 or more months was associated with a significant decrease in ovarian cancer risk compared to never breastfeeding (RR=0.66, 95% CI 0.46-0.96). For each month of breastfeeding the relative risk decreased by 2% (RR=0.98 per month, 95% CI 0.97-1.00).
CONCLUSIONS: These data support a linear inverse association between breastfeeding and risk of epithelial ovarian cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17450440     DOI: 10.1007/s10552-007-0130-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  48 in total

1.  The risks of not breastfeeding for mothers and infants.

Authors:  Alison Stuebe
Journal:  Rev Obstet Gynecol       Date:  2009

2.  Severe maternal morbidity and breastfeeding outcomes in the early post-natal period: a prospective cohort study from one English maternity unit.

Authors:  Marie Furuta; Jane Sandall; Derek Cooper; Debra Bick
Journal:  Matern Child Nutr       Date:  2015-02-26       Impact factor: 3.092

3.  Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women.

Authors:  Joellen M Schildkraut; Lauren C Peres; Traci N Bethea; Fabian Camacho; Deanna Chyn; Emily K Cloyd; Elisa V Bandera; Alicia Beeghly-Fadiel; Loren Lipworth; Charlotte E Joslin; Faith G Davis; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Veronica Wendy Setiawan; Malcolm C Pike; Anna H Wu; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2019-06-24       Impact factor: 2.506

4.  Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.

Authors:  Nan-Nan Luan; Qi-Jun Wu; Ting-Ting Gong; Emily Vogtmann; Yong-Lai Wang; Bei Lin
Journal:  Am J Clin Nutr       Date:  2013-08-21       Impact factor: 7.045

5.  Analysis of human breast milk cells: gene expression profiles during pregnancy, lactation, involution, and mastitic infection.

Authors:  Julie A Sharp; Christophe Lefèvre; Ashalyn Watt; Kevin R Nicholas
Journal:  Funct Integr Genomics       Date:  2016-02-24       Impact factor: 3.410

Review 6.  Use of fertility drugs and risk of ovarian cancer.

Authors:  Brenda Diergaarde; Michelle L Kurta
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

7.  Randomised trial comparing hand expression with breast pumping for mothers of term newborns feeding poorly.

Authors:  Valerie J Flaherman; Barbara Gay; Cheryl Scott; Andrew Avins; Kathryn A Lee; Thomas B Newman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2011-07-11       Impact factor: 5.747

8.  Breast-feeding the last born child and risk of ovarian cancer.

Authors:  Linda Titus-Ernstoff; Judy R Rees; Kathryn L Terry; Daniel W Cramer
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

Review 9.  Current understanding of risk factors for ovarian cancer.

Authors:  Thanasak Sueblinvong; Michael E Carney
Journal:  Curr Treat Options Oncol       Date:  2009-07-15

Review 10.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.